CliffBio
small molecule

ORPHENGESIC

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Loss of exclusivity—loss of exclusivity
CompanyGalt Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameORPHENGESIC
Active ingredientASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
Strength385MG;30MG;25MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 1998
Marketing statusRX

More from Galt Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ORPHENGESIC patent cliff — loss of exclusivity — | CliffBio